POSA40 Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) Versus Tiotropium Monotherapy in Patients with COPD in the UK
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.186
https://www.valueinhealthjournal.com/article/S1098-3015(21)01981-1/fulltext
Title :
POSA40 Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) Versus Tiotropium Monotherapy in Patients with COPD in the UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01981-1&doi=10.1016/j.jval.2021.11.186
First page :
Section Title :
Open access? :
No
Section Order :
10957